+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemostasis Diagnostic Devices And Equipment Global Market Report 2020

  • ID: 4871556
  • Report
  • December 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cook Medical
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Moog
  • MORE
Hemostasis Diagnostic Devices And Equipment Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global hemostasis diagnostic devices and equipment market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the hemostasis diagnostic devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hemostasis Diagnostic Devices And Equipment Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market:
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Product: Analyzers, Coagulation Instrument, Other Hemostasis Instruments , Reagents and Kits 2) By End User: Hospitals, Clinics, Independent Diagnostic, Laboratories, Others 3) By Device Technology: Automated, Semi-Automated, Manual
  • Companies Mentioned: C.R. Bard, Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cook Medical
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Moog
  • MORE
1. Executive Summary

2. Hemostasis Diagnostic Devices And Equipment Market Characteristics

3. Hemostasis Diagnostic Devices And Equipment Market Size And Growth
3.1. Global Hemostasis Diagnostic Devices And Equipment Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Hemostasis Diagnostic Devices And Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Hemostasis Diagnostic Devices And Equipment Market Segmentation
4.1. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Analyzers
  • Coagulation Instrument
  • Other Hemostasis Instruments
  • Reagents and Kits
4.2. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Independent Diagnostic
  • Laboratories
  • Others
4.3. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Device Technology, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Automated
  • Semi-Automated
  • Manual
5. Hemostasis Diagnostic Devices And Equipment Market Regional And Country Analysis
5.1. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market
6.1. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market Overview
6.2. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Hemostasis Diagnostic Devices And Equipment Market
7.1. China Hemostasis Diagnostic Devices And Equipment Market Overview
7.2. China Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Hemostasis Diagnostic Devices And Equipment Market
8.1. India Hemostasis Diagnostic Devices And Equipment Market Overview
8.2. India Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Hemostasis Diagnostic Devices And Equipment Market
9.1. Japan Hemostasis Diagnostic Devices And Equipment Market Overview
9.2. Japan Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Hemostasis Diagnostic Devices And Equipment Market
10.1. Australia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Hemostasis Diagnostic Devices And Equipment Market
11.1. Indonesia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Hemostasis Diagnostic Devices And Equipment Market
12.1. South Korea Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Hemostasis Diagnostic Devices And Equipment Market
13.1. Western Europe Hemostasis Diagnostic Devices And Equipment Market Overview
13.2. Western Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Hemostasis Diagnostic Devices And Equipment Market
14.1. UK Hemostasis Diagnostic Devices And Equipment Market Overview
14.2. UK Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Hemostasis Diagnostic Devices And Equipment Market
15.1. Germany Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Hemostasis Diagnostic Devices And Equipment Market
16.4. France Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market
17.1. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market Overview
17.2. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Hemostasis Diagnostic Devices And Equipment Market
18.1. Russia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Hemostasis Diagnostic Devices And Equipment Market
19.1. North America Hemostasis Diagnostic Devices And Equipment Market Overview
19.2. North America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Hemostasis Diagnostic Devices And Equipment Market
20.1. USA Hemostasis Diagnostic Devices And Equipment Market Overview
20.2. USA Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Hemostasis Diagnostic Devices And Equipment Market
21.1. South America Hemostasis Diagnostic Devices And Equipment Market Overview
21.2. South America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Hemostasis Diagnostic Devices And Equipment Market
22.1. Brazil Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Hemostasis Diagnostic Devices And Equipment Market
23.1. Middle East Hemostasis Diagnostic Devices And Equipment Market Overview
23.2. Middle East Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Hemostasis Diagnostic Devices And Equipment Market
24.1. Africa Hemostasis Diagnostic Devices And Equipment Market Overview
24.2. Africa Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Hemostasis Diagnostic Devices And Equipment Market Competitive Landscape And Company Profiles
25.1. Hemostasis Diagnostic Devices And Equipment Market Competitive Landscape
25.2. Hemostasis Diagnostic Devices And Equipment Market Company Profiles
25.2.1. C.R. Bard
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Baxter International Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Pfizer Inc.
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Johnson & Johnson
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Abbott Laboratories
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Hemostasis Diagnostic Devices And Equipment Market

27. Hemostasis Diagnostic Devices And Equipment Market Trends And Strategies

28. Hemostasis Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis

29. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • Cook Medical
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Moog
  • MORE
The hemostasis diagnostic devices and equipment market consists of sales of hemostasis diagnostic devices. Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. Hemostasis is the first step of healing a wound, it happens in three main stages, blood coagulation, platelet plug formation and lastly vasoconstriction. There are three types of devices which help speed up the hemostasis process, vascular closure devices (VCD), compression devices, and there are bandages coated with agents which will speeden the clotting process. With the help of hemostasis diagnostic devices we can predict the cause of bleeding during surgery by identifying any hemostatic defects which patients may have.

The global hemostasis diagnostic devices and equipment market was valued at about $3.2 billion in 2018 and is expected to grow to $4.16 billion at a CAGR of 6.8% through 2022.

The Hemostasis Diagnostic Devices And Equipment market has been geographically segmented into North America, Western Europe, APAC, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for Hemostasis Diagnostic Devices And Equipment and is expected to continue to do so during the forecast period

The increased liklihood of older people being diagnosed with a disease is drivng the number of surgeries such as cardio vascular diseases (CVD), using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries in elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery.
According to the American Heart Association report, 2013, americans older than 80 have a high risk of devoling a cardiovascular disease (CVD), around 83% of men and 87.1% of female will be suffering with any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis devices have been implemented widely.

The use of hemostasis devices in hospitals or clinics requires a very lengthy approval procedure which is restraining the market. Before hemostasis devices can enter the market for commericial use they have to clear the regulations set by the Code of Federal Regulations (title 21). The process of approval consists firstly identification of the device, secondly classification of the device and finally the date of pre-market approval (PMA) or the notice of completion of prescription drug plan (PDP) is required. It is a very long and time consuming approval process which discourages new entrants from entering this market. For example, Cardiva medical Inc. had to wait for a processing period of four months before they received approval to change the existing equipment with a newer and modern one.

Emergence of new and improved technology in the hemostasis diagnostic device and equipment market.
To improve the quality and success rate of operations, new and improved technology such as the collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result collagen-based closure device have been implemented. According to a study conducted by the American Journal of Neuroradiology in 2013 in which they surveyed 698 Angio-Seal closures, using the Angio seal reduced average time before mobilisation by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device which reduces the average time of hemostasis and betters the mobilization of the patient.

In the year 2018, Baxter international Inc., a leading American healthcare company acquired Mallinckrodt for $153 Million. The acquisition was done for the purchase and addition of hemostasis devices in the product portfolio of Baxter Inc. Mallinckrodt is an Irish–tax registered manufacturer of specialty pharmaceuticals and imaging agents. This acquisition was done to enhance the product portfolio of Baxter Inc. with hemostats, particularly Recothrom and Preveleak. These devices are useful in vascular reconstructions to achieve hemostasis by sealing the leakage mechanically. When the Preveleak hemostat device was implemented the average surgery time was reduced by 15%.

In 2018, Baxter international Inc., a leading American healthcare company acquired Mallinckrodt for $153 Million. The acquisition was done for the purchase and addition of hemostasis devices in the product portfolio of Baxter Inc. Mallinckrodt is an Irish–tax registered manufacturer of specialty pharmaceuticals and imaging agents. This acquisition was done to enhance the product portfolio of Baxter Inc. with hemostats, particularly Recothrom and Preveleak. These devices are useful in vascular reconstructions to achieve hemostasis by sealing the leakage mechanically. When the Preveleak hemostat device was implemented the average surgery time was reduced by 15%.

Major players in the market are C.R. Bard, Baxter International Inc., Pfizer Inc., Johnson & Johnson, Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
  • C.R. Bard
  • Baxter International Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Becton
  • Dickinson and Company
  • Chrono-Log Corporation
  • CSL Behring LLC
  • F. Hoffmann-La Roche Ltd.
  • Grifols
  • S.A.
  • HemCon Medical Technologies Inc.
  • Integra Life Sciences Corporation
  • Medtronic plc
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc.
  • Ethicon
  • Boston Scientific
  • Olympus
  • Medtronic
  • Cook Medical
  • Halyard
  • Medline
  • Pentax
  • ConMed
  • Fujinon
  • Moog
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll